ForecastedResearch announcementOpportunity FOR-AI-27-001

Martin Delaney Collaboratories for HIV Cure Research

National Institutes of Health · Department of Health and Human Services

At a glance

Martin Delaney Collaboratories for HIV Cure Research is a forecasted federal cooperative agreement opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of August 19, 2026; forecast dates can change. Total estimated funding is $20M across about 6 awards. Applicant types listed as eligible include state governments, county governments, independent school districts, public colleges & universities, federally recognized tribal governments and 6 more. Cost sharing is not required. It is funded under Assistance Listing 93.855 (Allergy and Infectious Diseases Research).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Jun 10, 2025Forecast posted
Apr 21, 2026 (est.)Full notice expected
Aug 19, 2026 (est.)Application deadline
Mar 1, 2027 (est.)Est. award datenext date

Posted: Jun 10, 2025
Est. close date: Aug 19, 2026
Est. award date: Mar 1, 2027
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: $20,000,000
Implied average award: $3,333,333 calculated
Expected awards: 6
Cost sharing: Not required
Funding instrument: Cooperative Agreement
Opportunity category: Discretionary
Fiscal year: FY2027

Typical awards for this program (SAM.gov listing for ALN 93.855, not this notice): from $2,500 to $6,395,901 and the average $426,165.

Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.

Who can apply

State governments
County governments
Independent school districts
Public colleges & universities
Federally recognized tribal governments
Public & Indian housing authorities
Native American tribal organizations
501(c)(3) nonprofits
Private colleges & universities
For-profit organizations (not small businesses)
Small businesses

Can your organization apply?

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the Martin Delaney Collaboratories (MDCs) for HIV Cure Research. The goal of the MDC program is to develop strategies to control viral replication without the need for lifelong antiretroviral therapy, with an ultimate goal of completely eradicating HIV reservoirs from the individual. The program will also address the unique needs of children living with HIV. The MDC program will accelerate HIV cure research by fostering strategic collaborations among academic institutions, scientists in government, the private sector, and community stakeholders. The program provides economies of scale by leveraging shared reagents, research resources, and specialized technologies in support of basic, translational, and clinical research. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

How to apply

0 of 8 done · progress saved in this browser

Read the full announcement (NOFO)Eligibility, evaluation criteria, page limits and required attachments are in the full notice on Grants.gov. Open ↗
Confirm eligibility and fitCheck your organization type above; no cost sharing is required.
Register (or renew) in SAM.gov and get a UEIFree. New registrations can take several weeks; registrations must be renewed every year. Open ↗
Set up Grants.gov accessCreate a Grants.gov account and make sure someone has the Authorized Organization Representative (AOR) role. Open ↗
Watch for the full noticeThe agency estimates posting it around April 21, 2026. Save this grant to track changes.
Prepare narrative, budget and attachmentsFollow the notice's format exactly — page limits and required forms are common reasons applications are rejected.
Ask the agency contact any questions earlyDiane Lawrence, Ph.D. National Institute of Allergy and Infectious Diseases (NIAID) · diane.lawrence2@nih.gov Open ↗
Submit before August 19, 2026Submit a few days early and keep your Grants.gov confirmation and validation emails.

Assistance Listing

What is an ALN?

93.855Allergy and Infectious Diseases ResearchProgram →

Reported obligations under ALN 93.855

Historical data · not a prediction

FY24

$4.07B

FY25

$4.38B

FY26

$4.3B est.

Source: SAM.gov Assistance Listing 93.855. Program-wide totals, not awards from this specific opportunity.

Who was funded under ALN 93.855

Historical data · not a prediction

Since October 1, 2023, 15,420 grant awards had funding actions under Allergy and Infectious Diseases Research, with 10,548 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.

THE JOHNS HOPKINS UNIVERSITY$430M
FRED HUTCHINSON CANCER CENTER$420M
REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE$407M
DUKE UNIVERSITY$352M
WASHINGTON UNIVERSITY, THE$346M

Recipients, states, recent awards and sub-awards →Source: USAspending.gov.

Agency contact (as published)

Diane Lawrence, Ph.D. National Institute of Allergy and Infectious Diseases (NIAID)
diane.lawrence2@nih.gov
240-627-3202

Quick answers

Is “Martin Delaney Collaboratories for HIV Cure Research” open for applications yet?

Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around April 21, 2026. Forecast details and dates can change.

Who is eligible to apply for “Martin Delaney Collaboratories for HIV Cure Research”?

The official notice names these applicant types as eligible: State governments, County governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Private colleges & universities, For-profit organizations (not small businesses) and Small businesses. Additional restrictions may apply; review the full notice.

How much funding is available through “Martin Delaney Collaboratories for HIV Cure Research”?

Per the notice, total estimated program funding is $20,000,000 and the agency expects to make about 6 awards.

How do I apply for “Martin Delaney Collaboratories for HIV Cure Research”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity FOR-AI-27-001), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

ForecastedResearchALN 93.855